Skip to main content
SpringerLink
Log in

Can Eradication Therapy for Helicobacter pylori Really Improve the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review

  • Review Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Helicobacter pylori has recently been postulated to play a role in the pathogenesis of autoimmune diseases, including idiopathic thrombocytopenic purpura (ITP). We investigated the prevalence ofH pylori infection and the effects of its eradication in 61 patients with ITP.H pylori infection was found in 50 patients (83%), an incidence significantly higher than not only healthy volunteers in Japan (60%) but also subjects in other reported ITP series (approximately 43%–71%). In our study, the mean age ofH pylori-positive ITP patients (58.0 years) was significantly higher than that ofH pylori-negative ITP patients (40.5 years). Bacterium eradication efforts were performed in 29 infected ITP patients and succeeded in 27 patients (93%). The 29 patients with eradicatedH pylori infections showed significant increases in platelet counts compared with patients with uneradicated infections or who wereH pylori-negative. During the follow-up period (median, 11.0 months), 16 (55%) of 29 patients achieved a major or a minor response. The patients who achieved a major response had not received previous prednisolone therapy, suggesting a relationship between prednisolone therapy and the response to eradication efforts.The assessment ofH pylori infection and its eradication should be attempted in cases of ITP, because this approach may be a good new strategy for treating some ITP patients, especially elderly Japanese patients. Some regional factors have been suggested as causes ofH pylori-associated ITP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Graham DY, Lew GM, Klein PD, et al. Effect of treatment ofHelicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study.Ann Intern Med. 1992;116:705–708.

    Article  PubMed  CAS  Google Scholar 

  2. Forman D, Newell DG, Fullerton F, et al. Association between infection withHelicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.BMJ. 1991;302:1302–1305.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Zentilin P, Savarino V, Garnero A, Accardo S, Seriolo B. IsHelicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis?Gastroenterology. 1999;116:503–504.

    Article  PubMed  CAS  Google Scholar 

  4. De Luis DA, Varela C, de la Calle H, et al.Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis.J Clin Gastroenterol. 1998;26:259–263.

    Article  PubMed  Google Scholar 

  5. Gasbarrini A, Franceschi F. Autoimmune diseases andHelicobacter pylori infection.Biomed Pharmacother. 1999;53:223–226.

    Article  PubMed  CAS  Google Scholar 

  6. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication ofHelicobacter pylori.Lancet. 1998;352:878.

    Article  PubMed  CAS  Google Scholar 

  7. Negrini R, Savio A, Poiesi C, et al. Antigen mimicry betweenHelicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis.Gastroenterology. 1996;111:655–665.

    Article  PubMed  CAS  Google Scholar 

  8. McCrae KM, Bussel JB, Mannucci PI, Remuzzi G, Cines DB. Platelets: an update on diagnosis and management of thrombocytopenic disorders.Hematology (Am Soc Hematol Educ Prog). 2001:282–305.

    Article  Google Scholar 

  9. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor.Am J Med. 1997; 103:114–120.

    Article  PubMed  CAS  Google Scholar 

  10. Nagamine T, Ohtuka T, Takehara K, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection.J Hepatol. 1996;24:135–140.

    Article  PubMed  CAS  Google Scholar 

  11. Hohmann AW, Booth K, Peter V, Gordon DL, Comacchio RM. Common epitope on HIV p24 and human platelets.Lancet. 1993; 342:1274–1275.

    Article  PubMed  CAS  Google Scholar 

  12. Grimaz S, Damiani D, Brosolo P, Skert C, Geromin A, de Pretis G. Resolution of thrombocytopenia after treatment forHelicobacter pylori: a case report.Haematologica. 1999;84:283–284.

    PubMed  CAS  Google Scholar 

  13. Emilia G, Longo G, Luppi M, et al.Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura.Blood. 2001;97:812–814.

    Article  PubMed  CAS  Google Scholar 

  14. Kohda K, Kuga T, Kogawa K, et al. Effect ofHelicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura.Br J Haematol. 2002;118:584–588.

    Article  PubMed  Google Scholar 

  15. Jarque I, Andreu R, Llopis I, et al. Absence of platelet response after eradication ofHelicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura.Br J Haematol. 2001;115:1002–1003.

    Article  PubMed  CAS  Google Scholar 

  16. Asaka M, Kimura T, Kudo M, et al. Relationship ofHelicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.Gastroenterology. 1992;102:760–766.

    Article  PubMed  CAS  Google Scholar 

  17. Fukuda Y, Tomita Y, Sakagami T, Shimoyama T. Epidemiology ofH pylori infection [in Japanese].Nippon Rinsho. 2002;60(suppl 2):40–48.

    PubMed  Google Scholar 

  18. McMillan R. Therapy for adults refractory chronic immune thrombocytopenic purpura.Ann Int Med. 1997;126:307–314.

    Article  PubMed  CAS  Google Scholar 

  19. Kawai T, Kawakami K, Kudo S, et al. A new serum antibody test kit for evaluation ofHelicobacter pylori eradication.Int Med. 2002;41:780–783.

    Article  CAS  Google Scholar 

  20. Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes.Blood. 2000;96:3671–3674.

    PubMed  CAS  Google Scholar 

  21. Cabtree JE, Lindley IJ. Mucosal interleukin-8 andHelicobacter pylori-associated gastroduodenal disease.Eur J Gastroenterol Hepatol. 1994;6(suppl l):S33-S38.

    Google Scholar 

  22. Shimoyama T, Crabtree JE. Bacterial factors and immune pathogenesis inHelicobacter pylori infection.Gut. 1998;43(suppl 1):S2-S5.

    PubMed  PubMed Central  Google Scholar 

  23. Akiyama H, Onozawa Y. Effect of omeprazole in chronic idiopathic thrombocytopenic purpura.Am J Hematol. 1998;57:91–92.

    Article  PubMed  CAS  Google Scholar 

  24. Luzza F, Imeneo M, Maletta M, et al. Suggestion against an oral-oral rout of transmission forHelicobacter pylori infection: a seroepidemiological study in a rural area.Dig Dis Sci. 1998;43:1488–1492.

    Article  PubMed  CAS  Google Scholar 

  25. Tovey FI, Hobsley M. IsHelicobacter pylori the primary cause of duodenal ulceration?J Gastroenterol Hepatol. 1999;14:1053–1056.

    Article  PubMed  CAS  Google Scholar 

  26. George JN. Initial management of adults with idiopathic (immune) thrombocytopenic purpura.Blood Rev. 2002;16:37–38.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, Tokyo Medical University, 6-7-1, Nishishinjuku, Shinjuku-ku, 160-0023, Tokyo, Japan

    Keiko Ando, Takashi Shimamoto, Tetsuzo Tauchi, Yoshikazu Ito, Yuzuru Kuriyama, Akihiko Gotoh, Keisuke Miyazawa, Yukihiko Kimura & Kazuma Ohyashikia

  2. Fourth Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan

    Takashi Kawai

Authors
  1. Keiko Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Shimamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tetsuzo Tauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshikazu Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuzuru Kuriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akihiko Gotoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keisuke Miyazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yukihiko Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Takashi Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kazuma Ohyashikia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Shimamoto.

About this article

Cite this article

Ando, K., Shimamoto, T., Tauchi, T. et al. Can Eradication Therapy for Helicobacter pylori Really Improve the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review. Int J Hematol 77, 239–244 (2003). https://doi.org/10.1007/BF02983780

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02983780

Key words

Search

Navigation